Гематология
1411 статей · 38 журналов
Журналы подкатегории (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (89)
- Blood Advances · Elsevier (89)
- Journal of Thrombosis and Haemostasis · Elsevier (85)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (80)
- Thrombosis Research · Elsevier (80)
- British Journal of Haematology · Wiley (75)
- European Journal of Haematology · Wiley (74)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Blood · Elsevier (65)
- Vox Sanguinis · Wiley (65)
- Annals of Oncology · Elsevier (62)
- American Journal of Hematology · Wiley (58)
- Haemophilia · Wiley (58)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion · Wiley (49)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- The Lancet Haematology · Elsevier (28)
- Seminars in Oncology · Elsevier (27)
- Experimental Hematology · Elsevier (21)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (14)
- Transfusion Medicine · Wiley (13)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
- Liberal versus restrictive transfusion in haemato‐oncological patients undergoing autologous stem cell transplantation: A single‐centre experience
- A Myeloma Masquerade: CCND3‐Rearranged Plasma Cell Myeloma Mimicking Lymphoplasmacytic Lymphoma
- Combination Therapy of Vinblastine, Prednisolone, Methotrexate, and 6‐Mercaptopurine as a Front‐Line Therapy for Adult Patients With Langerhans Cell Histiocytosis
-
Challenges of human platelet lysate production: Results of an International Survey of the ISBT Working Party on Cellular Therapies
Abstract Background and Objectives Global demand is rising for human platelet lysate (HPL) in the manufacture of cell‐based medicinal products, but platelet resources are scarce. As protocols for the production process and quality...
-
Sex‐ and age‐specific daily and seasonal rhythms in haemoglobin and ferritin among Dutch blood donors
Abstract Background and Objectives Intra‐individual haemoglobin (Hb) and ferritin variation is often overlooked in clinical practice, yet may be relevant where levels are around the cut‐offs. We characterised Hb and ferritin...
- Association of TNFAIP3 Polymorphisms With Bleeding Phenotypes and FVIII Inhibitor Development in Patients With Hemophilia A: A Case‐Control Study
- Socio‑Economic and Education Profile of Children With Haemophilia A Receiving Prophylaxis and Their Families: Results From a Brazilian Cohort
-
Association Between the Time of Day of Post‐Transplant Cyclophosphamide Administration and Haemorrhagic Cystitis After Allogeneic Haematopoietic Stem Cell Transplantation
ABSTRACT Objective To evaluate the impact of the time‐of‐day (daytime vs. nighttime) of the infusion of post‐transplantation cyclophosphamide (PTCy) on the occurrence of haemorrhagic cystitis (HC) in adult patients undergoing allogeneic...
-
Elevated Risks for Depression and Anxiety Following Diagnosis of Multiple Myeloma
ABSTRACT Background Patients with multiple myeloma (MM) may be particularly vulnerable to depression and anxiety following diagnosis due to high disease burden, treatment‐related side effects, and the incurable nature of the disease....
- Interpreting the Association Between Plasma Citrulline and Bloodstream Infection in Pediatric Acute Myeloid Leukemia
- 100 Years of von Willebrand Disease (VWD): Comparison of Historical and Contemporary von Willebrand Factor (VWF) Activity Assays in the Laboratory Identification of VWD
-
Plasma Exchange and Daratumumab for Myeloma Cast Nephropathy
ABSTRACT Multiple myeloma light chain cast nephropathy (LCCN) is often treated with plasma exchange (PLEX) or the anti‐CD38 monoclonal antibody, daratumumab. However, rigorous studies supporting these therapies for LCCN are limited....
- Three‐buffy‐coat platelet concentrates: Evaluation of a Welsh blood supply chain contingency strategy with wider opportunities for European practice
- Oral Azacitidine Maintenance After CPX‐351 in Transplant‐Ineligible Patients With Therapy‐Related or Myelodysplasia‐Related Acute Myeloid Leukemia
- Expanding the military blood donor pool through non‐donor recruitment
- From Platelet‐Transfusion Risk to the Decision That Matters in Thrombotic Thrombocytopenic Purpura
-
BCMA‐Targeted Immunotherapy in Early Relapsed/Refractory Multiple Myeloma: Mechanisms, Clinical Evidence, and Practical Management
ABSTRACT Background B‐cell maturation antigen (BCMA), a plasma cell‐restricted member of the tumor necrosis factor receptor superfamily, has emerged as the premier immunotherapeutic target in Multiple Myeloma (MM). Methods We performed...
- Immune platelet transfusion refractoriness associated with anti‐CD36 alloimmunisation in a Brazilian patient with platelet CD36 deficiency
-
A Pooled CRISPR Screen Reveals Genes Critical for Erythroblast Enucleation
ABSTRACT Terminal erythroid differentiation involves dramatic cellular remodeling that culminates in the expulsion of the nucleus, a process known as enucleation. While enucleation is conserved across mammals and is crucial for the...
- Monitoring of lymphocyte subsets in regular blood donors
- Composite Complication Endpoints May Obscure Bleeding Risk in Pediatric Central Venous Catheterization
- Pulmonary Alveolar Proteinosis After Allogeneic Stem Cell Transplant in a Patient Undergoing Multiagent Chronic Graft‐Versus‐Host‐Disease Treatment Including Axatilimab
-
Chromosomal Abnormalities, Drug Sensitivity and Resistance in Hematological Malignancies: A Comprehensive Overview by the Francophone Group of Hematological Cytogenetics (GFCH)
ABSTRACT Chromosomal abnormalities have a major clinical impact on hematological malignancies, particularly with regard to treatment strategies. To preserve and consolidate fundamental knowledge in this rapidly evolving field, the...
- Exploring the Patient Perspective of Gene Therapy for Sickle Cell Disease
- HMOX1‐Associated Neutrophil Engraftment in Pediatric HSCT Requires Evidence Beyond an Early Time Window
- Schistocytes Are a Clue, Not a Gatekeeper in Thrombotic Microangiopathy
-
Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B‐Cell Lymphoma
ABSTRACT Background Extranodal (EN) involvement is common in diffuse large B‐cell lymphoma (DLBCL), but current prognostic models inadequately capture the anatomical complexity of EN dissemination. We evaluated primary multifocal...
-
Proteomic Profiling of Nodal T‐Follicular Helper Cell Lymphoma Reveals Distinct Biological Signatures and Improves Prognostic Stratification Beyond the IPI
ABSTRACT Nodal T‐follicular helper cell lymphoma (nTFHL), most commonly of angioimmunoblastic type, exhibits heterogeneous clinical outcomes that are not fully explained by current clinical and biological variables. While genetic...
-
Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First‐Line Treatment in Patients With Newly Diagnosed Non‐Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study
ABSTRACT Objectives The MYLENE non‐interventional study (NIS) aimed to close the gap in real‐world data on the experience and satisfaction with subcutaneous (sc) and intravenous (iv) daratumumab application in patients with newly...
- Steroid Response Prediction in Children With Diamond–Blackfan Anemia Requires Age at Treatment, Not Diagnosis